National Guideline Clearinghouse | Guidelines by Topic: Ovarian Neoplasms

http://guideline.gov/browse/by-topic-detail.aspx?id=47926&ct=1

www.ahrq.gov/

Visit: National Quality Measures Clearinghouse | Health Care Innovations Exchange | AHRQ HomeSign In

Help| RSS|  Subscribe to weekly e-mail | Site map| Contact us| For web developers

Search

Search Tips   Advanced Search   About Search

 

Browse

• - By Topic
• - By Organization
• - Guidelines in Progress
• - Guideline Index
• - Guideline Archive
• - Related NQMC Measures

Guidelines by Topic

Disease/Condition > Diseases (2434) > Neoplasms (605) > Neoplasms by Site(471) > Endocrine Gland Neoplasms (69) >

Ovarian Neoplasms (26)

Narrow:

Granulosa Cell Tumor (1)
Hereditary Breast and Ovarian Cancer Syndrome (1)

Search WithinSearch within:    Go

Sort results by:  Relevance    Publication date

Filter results by:   All Years  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2000  1999  1998  1997 

1-20 of 26   Next >
1.   Cancer screening. 2004 May (revised 2011 Nov). NGC:008900 University of Michigan Health System - Academic Institution. View all guidelines by the developer(s) Compare Selected
2.   Management of suspected ovarian masses in premenopausal women. 2011 Nov. NGC:008987 British Society for Gynecological Endoscopy - Medical Specialty Society; Royal College of Obstetricians and Gynaecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
3.   Ovarian cancer. The recognition and initial management of ovarian cancer. 2011 Apr. NGC:008756 National Collaborating Centre for Cancer - National Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
4.   Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy. 1996 Feb (revised 2011). NGC:008496 Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
5.   Epithelial ovarian, fallopian tube, and primary peritoneal cancer.2010 Jul. NGC:008711 Alberta Health Services, Cancer Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
6.   ACR practice guideline for the performance of magnetic resonance imaging (MRI) of the soft-tissue components of the pelvis. 2010. NGC:008416 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
7.   ACR–ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. 1996 (revised 2010). NGC:008422 American College of Radiology - Medical Specialty Society; American Society for Radiation Oncology - Professional Association. View all guidelines by the developer(s) Compare Selected
8.   Ovarian carcinoma. 2009 Oct 1. NGC:008147 Comprehensive Cancer Centre the Netherlands - Disease Specific Society. View all guidelines by the developer(s) Compare Selected
9.   Gynaecological ultrasound examination. 2001 Jan 5 (revised 2009 Sep 24). NGC:008185 Finnish Medical Society Duodecim - Professional Association. View all guidelines by the developer(s) Compare Selected
10.   Initial evaluation and referral guidelines for management of pelvic/ovarian masses. 2009 Jul. NGC:007380 Gynecologic Oncologists of Canada - Disease Specific Society; Society of Canadian Colposcopists - Professional Association; Society of Obstetricians and Gynaecologists of Canada - Medical Specialty Society.View all guidelines by the developer(s) Compare Selected
11.   Hereditary breast and ovarian cancer syndrome. 2009 Apr. NGC:007204 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
12.   SAGES guidelines for the use of laparoscopic ultrasound. 2009 Mar. NGC:007265 Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
13.   PET imaging in ovarian cancer: recommendations. 2009 Jan 19. NGC:007452 Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s) Compare Selected
14.   ACR Appropriateness Criteria® clinically suspected adnexal mass. 1996 (revised 2009). NGC:007815 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
15.   ACR Appropriateness Criteria® ovarian cancer screening. 1996 (revised 2009). [NGC Update Pending] NGC:007938 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
16.   ACR Appropriateness Criteria® staging and follow-up of ovarian cancer. 1996 (revised 2009). [NGC Update Pending] NGC:007819 American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
17.   Gynaecological cancer. In: Suspected cancer in primary care: guidelines for investigation, referral and reducing ethnic disparities. 2009 Sep 1. NGC:007549 New Zealand Guidelines Group - Nonprofit Organization. View all guidelines by the developer(s) Compare Selected
18.   Use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. 2009. NGC:007630 National Academy of Clinical Biochemistry - Professional Association.View all guidelines by the developer(s) Compare Selected
19.   Elective and risk-reducing salpingo-oophorectomy. 1999 Sep (revised 2008 Jan). NGC:006287 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
20.   Management of adnexal masses. 2007 Jul. NGC:006539 American College of Obstetricians and Gynecologists - Medical Specialty Society. View all guidelines by the developer(s) Compare Selected
1-20 of 26   Next >

You Are Here: U.S. Preventive Services Task Force > Topic Index > Screening for Ovarian Cancer

Screening for Ovarian Cancer

---

This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for ovarian cancer.

---

Current Recommendation

Release Date: September 2012

• The USPSTF recommends against screening for ovarian cancer in women. 
  Grade: D Recommendation.

Supporting Documents

Supporting Document	Related Items
Reaffirmation Recommendation Statement	Clinical Summary (PDF File, 58 KB; PDF Help)
	Consumer Fact Sheet (PDF File, 118 KB; PDF Help)
	2004 Recommendation Statement (PDF File, 188 KB; PDF Help)
Reaffirmation Evidence Report (PDF File, 84 KB;PDF Help)	2012 Addendum (PDF File, 112 KB; PDF Help)
	2004 Evidence Report (PDF File, 182 KB; PDF Help)

Current as of September 2012

---

Internet Citation:

Screening for Ovarian Cancer, Topic Page. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsovar.htm

---

 

Privacy Policy  Terms of Use  Accessibility  Freedom of Information Act Web Site DisclaimersContact Us

USPSTF Program Office   540 Gaither Road, Rockville, MD 20850

http://www.uspreventiveservicestaskforce.org/uspstf/uspsovar.htm

Sent from my iPhone

National Guideline Clearinghouse | Complications of colonoscopy.

http://guideline.gov/content.aspx?f=rss&id=37852


Sent from my iPhone

CME -- Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis

Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysis

http://cme.alphamedpress.org/cgi/hierarchy/ampcme_course;ONC-17-9-1204

CME -- Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival

Lymphocele and Ovarian Cancer: Risk Factors and Impact on Survival

About this course

• Released: September 24, 2012
• Expires: September 24, 2014
• Time to Complete: 1.00 hour(s)
• Medium: Internet Online

http://cme.alphamedpress.org/cgi/hierarchy/ampcme_course;ONC-17-9-1198

Sent from my iPhone

WEBINAR: Infection Control and Prevention in Outpatient Oncology Clinics | CDC Foundation

Monday, September 24th

 1:00–2:00 p.m. EDT

Register at no cost

http://www.cdcfoundation.org/preventcancerinfections/webinar

Sent from my iPhone

Nanoparticles: the future for platinum drugs or a research red herring?, Nanomedicine, Future Medicine

Nanoparticles: the future for platinum drugs or a research red herring?, Nanomedicine, Future Medicine

ReachMD - Program - Vitamins, Herbs, and Supplements: The "Real Scoop" on Evidence

ReachMD - Program - Vitamins, Herbs, and Supplements: The "Real Scoop" on Evidence

Program Details

Vitamins, Herbs, and Supplements: The "Real Scoop" on Evidence

Program Description

This discussion focuses on the current state of evidence behind vitamins, herbs, and supplements in popular demand. What does the latest research recommend for use, and what should we be avoiding? Featured is Dr. Mark Moyad, the Jenkins/Pokempner Director of Preventive & Complementary Medicine at the University of Michigan Medical Center. Dr, Brian McDonough hosts.

Series

Clinician's Roundtable

New Chemotherapy Strategy Emerges in Ovarian Cancer

New Chemotherapy Strategy Emerges in Ovarian Cancer

"...The noteworthy results stem from Japanese Gynecologic Oncology Group (JGOG) trial 3016, which established a significant survival benefit for patients who received dose-dense weekly paclitaxel plus carboplatin versus the conventional dosing schedule for those two drugs.^1..."

MyChart: One Toronto hospital’s e-health triumph - The Globe and Mail

http://m.theglobeandmail.com/life/health-and-fitness/health/mychart-one-toronto-hospitals-e-health-triumph/article4557629/?service=mobile

Myriad gene patent case could impact patients, research - baltimoresun.com

http://www.baltimoresun.com/health/bs-hs-brca-patents-20120922,0,2928317.story


Sent from my iPhone